Method for stabilizing hemoglobin and reagents for performing the same

US11385243B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11385243-B2
Application numberUS-201916355498-A
CountryUS
Kind codeB2
Filing dateMar 15, 2019
Priority dateMar 27, 2018
Publication dateJul 12, 2022
Grant dateJul 12, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A stool resuspension solution comprising a hemoglobin stabilization reagent is provided. In some embodiments, the hemoglobin stabilization reagent may be an osmolyte, a polyvalent cation, a sugar or polysaccharide and, optionally, a polyvalent cation, a protoporphyrin, or an HRP stabilization component and, optionally, a polyvalent cation. A method of stabilizing hemoglobin in a stool sample in the solution is also provided, as well as a sample collection device containing the solution.

First claim

Opening claim text (preview).

We claim: 1. A composition comprising: a stool resuspension solution comprising: a buffer; and a protoporphyrin complexed with Cr 3+ or Co 3+ , wherein the concentration of the protoporphyrin complexed with Cr 3+ is 1.25-5 μM and the concentration of the protoporphyrin complexed with Co 3+ is 2.5-10 μM, wherein the protoporphyrin complexed with Cr 3+ or Co 3+ of is effective to stabilize hemoglobin. 2. The composition of claim 1 , wherein the protoporphyrin is protoporphyrin IX complexed with Cr 3+ and the concentration of protoporphyrin IX complexed with Cr 3+ is 1.5-4.5 μM. 3. The composition of claim 1 , wherein the protoporphyrin is protoporphyrin IX complexed with Co 3+ and the concentration of protoporphyrin IX complexed with Co 3+ is 3-5 μM. 4. The composition of claim 1 , wherein the solution has a pH in the range of pH 6.5 to pH 7.4. 5. The composition of claim 2 , wherein the pH of the solution is in the range of pH 6.9 to pH 7.4. 6. The composition of claim 3 , wherein the pH of the solution is in the range of pH 6.5 to pH 7.4. 7. The composition of claim 1 , wherein a stool sample is suspended in the solution. 8. The composition of claim 1 , wherein the buffer is Tris buffer and the solution further comprises bovine serum albumen, polysorbate 20, sodium azide, sodium chloride, ethylenediaminetetraacetic acid, and gentamicin. 9. A method of stabilizing hemoglobin in a stool sample, comprising: combining the stool sample with a stool resuspension solution comprising a buffer and a protoporphyrin complexed with Cr 3+ or Co 3± ; to produce a suspension; and maintaining the suspension for a period of time, wherein the concentration of the protoporphyrin complexed with Cr 3+ is 1.25-5 μM and the concentration of the protoporphyrin complexed with Co 3+ is 2.5-10 μM, and wherein the protoporphyrin complexed with Cr 3+ or Co 3+ increases stability of hemoglobin. 10. The method of claim 9 , wherein the method comprises shipping the suspension to a remote location. 11. A method of analyzing a stool sample, comprising: (a) receiving, from a remote location, a composition comprising: (i.) a stool sample; and (ii.) a stool resuspension solution comprising a buffer and a protoporphyrin complexed with Cr 3+ or Co 3+ , wherein the concentration of the protoporphyrin complexed with Cr 3+ is 1.25-5 μM and the concentration of the protoporphyrin complexed with Co 3+ is 2.5-10 μM, and wherein the protoporphyrin complexed with Cr 3+ or Co 3+ increases stability of hemoglobin; wherein the stool sample is suspended in the solution; and (b) measuring the amount of hemoglobin in the composition. 12. The method of claim 11 , further comprising measuring the amount of one or more colorectal cancer tumor markers in the sample. 13. The method of claim 11 , wherein the protoporphyrin is protoporphyrin IX complexed with Cr 3+ and the concentration of protoporphyrin IX complexed with Cr 3+ is 1.5-4.5 μM. 14. A sample collection device comprising: a sample collection container having an open end; a stool resuspension solution comprising a buffer and a protoporphyrin complexed with Cr 3+ or Co 3+ , wherein the concentration of the protoporphyrin complexed with Cr 3+ is 1.25-5 μM and the concentration of the protoporphyrin complexed with Co 3+ is 2.5-10 μM, and wherein the protoporphyrin complexed with Cr 3+ or Co 3+ increases stability of is effective to stabilize hemoglobin; and a stool sampling rod comprising a distal beveled tip for scooping and/or scraping a sample of stool, wherein the distal end of the sampling rod is dimensioned to be inserted into the sample collection container and the proximal end of the sampling rod is adapted to connect with the open end of the sample collection container, thereby sealing distal end of the sampling rod within the device. 15. The sample collection device of claim 14 , wherein the sample collection container and sampling rod connect via a screw fit. 16. The sample collection device of claim 14 , wherein the protoporphyrin is protoporphyrin IX complexed with Cr 3+ and the concentration of protoporphyrin IX complexed with Cr 3+ is 1.5-4.5 μM. 17. The sample collection device of claim 14 , wherein the protoporphyrin is protoporphyrin IX complexed with Co 3+ and the concentration of protoporphyrin IX complexed with Co 3+ is 3-5 μM. 18. The method of claim 11 , wherein the protoporphyrin is protoporphyrin IX complexed with Co 3+ and the concentration of protoporphyrin IX complexed with Co 3+ is 3-5 μM. 19. The sample collection device of claim 14 , wherein the stool resuspension solution is within the container. 20. The composition of claim 8 , wherein the concentration of protoporphyrin IX complexed with Cr 3+ is 2.5 μM. 21. The composition of claim 20 , wherein the pH of the composition is 6.9-7.4. 22. The composition of claim 8 , wherein the concentration of protoporphyrin IX complexed with Co 3+ is 4 μM. 23. The composition of claim 22 , wherein the pH of the composition is 6.9-7.4.

Assignees

Inventors

Classifications

  • of the large intestine, e.g. colon, rectum or anus · CPC title

  • Preservation or perfusion media · CPC title

  • Haemoglobins; Myoglobins · CPC title

  • for collecting, storing or administering blood, plasma or medical fluids {(multiple bags systems for separating or storing blood components A61M1/0209); Infusion or perfusion containers} · CPC title

  • Details; Accessories therefor (A61J7/00 takes precedence; openers B65D, B67B7/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11385243B2 cover?
A stool resuspension solution comprising a hemoglobin stabilization reagent is provided. In some embodiments, the hemoglobin stabilization reagent may be an osmolyte, a polyvalent cation, a sugar or polysaccharide and, optionally, a polyvalent cation, a protoporphyrin, or an HRP stabilization component and, optionally, a polyvalent cation. A method of stabilizing hemoglobin in a stool sample in…
Who is the assignee on this patent?
Exact Sciences Corp
What technology area does this patent fall under?
Primary CPC classification G01N33/721. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).